Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.
about
Analysis of coding variants in the betacellulin gene in type 2 diabetes and insulin secretion in African American subjectsA gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucoseTreatment of prediabetesType 2 diabetes can be prevented with early pharmacological interventionSystems biology approach reveals genome to phenome correlation in type 2 diabetesDevelopment of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic diseaseHeat shock protein 60 modified with O-linked N-acetylglucosamine is involved in pancreatic beta-cell death under hyperglycemic conditionsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialCharacterization of hearing loss in aged type II diabeticsAbnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphismStudy Protocol: insulin and its role in cancerAryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: Mutation detection, case-control studies, and gene expression analysis.The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasisRole of diabetes in the development of acute respiratory distress syndrome.Utility of homeostasis model assessment of beta-cell function in predicting diabetes in 12,924 healthy Koreans.Weight loss therapy improves pancreatic endocrine function in obese older adultsNutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models.The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic beta-cell dysfunction.Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.Fasting plasma leptin level is a surrogate measure of insulin sensitivity.FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.Insulin sensitiser drugs.Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesTissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice.Clinical review of glimepiride.Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.Genetic Variations in the Kir6.2 Subunit (KCNJ11) of Pancreatic ATP-Sensitive Potassium Channel Gene Are Associated with Insulin Response to Glucose Loading and Early Onset of Type 2 Diabetes in Childhood and Adolescence in Taiwan.Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans.Genetic determinants of type 2 diabetes mellitus.Impact of ENPP1 K121Q on change of insulin resistance after web-based intervention in Korean men with diabetes and impaired fasting glucoseObstructive sleep apnea and metabolic dysfunction in polycystic ovary syndromeOxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemiaMouse models of insulin resistance.Current oral agents for type 2 diabetes. Many options, but which to choose when?AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration.Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease.The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation.
P2860
Q21261450-B86DC5AF-A419-421A-95E6-482ABEC029CFQ22003951-9B0862D3-0050-4CBD-AD5B-D427502B39A7Q24240715-208F04CC-6754-4BC6-A73C-9B0FCC38F393Q26783350-7F7A7FD4-9B3F-4832-A089-03CC598D0FF8Q27694430-696A0E95-9666-4272-8506-E42C4A265CF0Q28484866-5F410287-BD84-4A9D-AE83-9997D8095800Q28510789-D848AD4F-555C-45EB-8828-FA5AA5E86623Q28568544-9BE17200-452D-45D3-96D3-1AA81D510230Q29994589-48283F24-15C9-41E2-A058-DD91071F4990Q30486612-69743E4D-77B2-41DF-8943-E66521687775Q33239296-B0E314A4-F3A6-4BE1-959D-F42668A6D2AAQ33303492-BD961839-9C86-4404-A296-4BDAEC05D3E5Q33320221-B63415EC-C3FC-40C3-8FD5-F1C1DE60900EQ33449878-A2F4D05C-2750-49B2-AC31-08433AEC6177Q33555078-6C60612F-D9AE-4898-B4DA-E64931333328Q33556817-2FB8C9DC-5855-4E00-9AD5-73CC2FBEFDEDQ33565059-BE0455A0-9FD8-4171-A749-71596A730CE1Q33843310-26344AD7-828B-47BC-A382-445518B9D439Q33937017-74EBA22F-5411-45D3-84C3-8FE5FFB4EE65Q33993695-E496B298-E840-48D6-B5E1-2F585F211DAEQ34014474-5457B3FE-5A57-437F-9C4A-21653AC9161CQ34032047-C52E27DC-4BBC-4192-87F7-CFA492A09DCFQ34032136-F6CEF999-2ACC-4A59-921C-3F561917FE0EQ34074912-46C8A8E9-BE69-4D92-9BBF-DC0A10965915Q34194600-E01AF119-EC58-4904-BD59-1EBCD9E24368Q34224255-2130B282-35A2-4D1A-B80E-8B8CB40FDFC3Q34240998-92FA2971-71F2-4559-A877-CAFB3D282DD4Q34292429-5D45E3E1-B126-4B11-B098-0E3DE6337DE6Q34306755-FD74F467-B3A4-447B-9205-F0917C936303Q34344990-68BC4376-50F1-4DDC-A531-E5493FDD9AD8Q34389390-76351368-311C-4BBA-AB19-F6412D5E5FD8Q34421519-803DB346-7F8C-49F5-965F-03410581BA34Q34429504-545AB22A-5C98-4E79-9DE8-E5350AB4296AQ34536081-C9A1E816-0405-47A5-B770-9BCF18017F28Q34569271-10350738-FBFD-44FA-9304-4CCF77A90CB5Q34588917-AF488119-46E0-4E99-8006-839A0D4399A6Q34663240-DEA011FD-0666-467F-AC56-29E16B8D6F60Q34746178-FF7B5F4E-CB11-4B98-9B1F-22AC4E9E2803Q34795541-8278B7BF-824F-4F20-85B0-B85BAB69638DQ35001130-EB6743BE-D170-4A9A-8E6B-5BD89DF7C1C7
P2860
Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Seminars in Medicine of the Be ...... ensate for insulin resistance.
@en
type
label
Seminars in Medicine of the Be ...... ensate for insulin resistance.
@en
prefLabel
Seminars in Medicine of the Be ...... ensate for insulin resistance.
@en
P2093
P1476
Seminars in Medicine of the Be ...... ensate for insulin resistance.
@en
P2093
P304
P356
10.1056/NEJM199603213341207
P407
P577
1996-03-01T00:00:00Z